NHS GREATER GLASGOW AND CLYDE

£100 million public-private investment to set up 20 research hubs across the UK, enhancing access to cutting-edge treatments and clinical trials in community settings, boosting economic growth and research delivery leadership in various medical conditions.

Susan McGowan's death, linked to the drug Mounjaro, marks the first UK fatality associated with GLP-1 receptor agonists. The drug, approved for diabetes and weight management, has raised concerns over serious side effects when obtained privately. The MHRA and Scottish Medicines Consortium have recommended its use, but regulatory shortcomings in online pharmacies pose risks. Despite clinical trials showing significant weight loss benefits and reduced cardiovascular events, the balance between benefits and risks remains a concern.

Dr. Malcolm Watson launched a health app and pilot scheme at Greenock Central Library, part of the 'Realistic Medicine' programme. Inverclyde Libraries, central to the programme, hosted the event with partners like Inverclyde community link workers. The 'Being a partner in my care' app aims to empower patients by providing pre-appointment treatment information. Inverclyde Libraries offer support to navigate the app, emphasizing the library's role as a health information hub.

Glasgow's Health Innovation Hub (HiH) aims to enhance the city's life science cluster, focusing on precision medicine. HiH, developed by Kadans Science Partner and The Living Laboratory, addresses infrastructure needs to attract startups and scale-ups, securing the Digital Health Validation Lab as its first tenant. The project emphasizes collaboration with Glasgow City Council and the University of Glasgow, aiming to support innovation and adaptability for future growth in life sciences.

The Health Innovation Hub in Glasgow, a precision medicine facility, has completed its primary structure. Located in the Glasgow Riverside Innovation District, it will offer 87,000ft² of lab and office space, welcoming the Digital Health Validation Lab as its first tenant. Developed by Kadans Science Partner in collaboration with The Living Laboratory, the hub aims to advance precision medicine, drive local economic growth, and improve patient outcomes. Scheduled to open in Autumn 2025, it will include community amenities and support for incoming occupiers.

The Health Innovation Hub in Glasgow has completed its primary structure, focusing on precision medicine. Located in the Glasgow Riverside Innovation District, it will house the Digital Health Validation Lab and provide 87,000ft² of lab and office space. Scheduled to open in Autumn 2025, it aims to boost Glasgow's life sciences sector and create new jobs.